These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3157722)

  • 1. Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients. A trait finding.
    Kathol RG
    J Affect Disord; 1985; 8(2):137-45. PubMed ID: 3157722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peak amplitude and frequency of urinary free cortisol excretion in patients with a history of major depressive disorder.
    Kathol RG; Gehris T
    Chronobiol Int; 1986; 3(4):281-7. PubMed ID: 3677209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circannual rhythm and peak frequency of corticosteroid excretion: relationship to affective disorder.
    Kathol RG
    Psychiatr Med; 1985; 3(1):53-63. PubMed ID: 3843452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Biol Psychiatry; 1990 Aug; 28(4):349-57. PubMed ID: 2397250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary free cortisol levels and dexamethasone suppression testing in organic affective disorder associated with hyperthyroidism.
    Kathol RG; Delahunt JW; Cooke R
    Am J Psychiatry; 1985 Oct; 142(10):1193-5. PubMed ID: 4037132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary free cortisol in psychotic depression.
    Anton RF
    Biol Psychiatry; 1987 Jan; 22(1):24-34. PubMed ID: 3790638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J; Plocka M
    J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone suppression test by measuring spot urinary free cortisol in depression.
    Tomitaka S; Sakamoto K; Tamura A; Kojima I; Fujita H
    Biol Psychiatry; 1996 Feb; 39(3):220-2. PubMed ID: 8837985
    [No Abstract]   [Full Text] [Related]  

  • 9. Seasonal variation and the results of the dexamethasone suppression test.
    Harris B; Watkins S; Newcombe R; Cook N; Read G; Riad-Fahmy D
    J Affect Disord; 1990 Oct; 20(2):115-20. PubMed ID: 2148325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol nonsuppression in depression: relationship to clinical variables.
    Roy A
    J Affect Disord; 1988; 14(3):265-70. PubMed ID: 2968388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
    Rubin RT; Poland RE; Lesser IM; Winston RA; Blodgett AL
    Arch Gen Psychiatry; 1987 Apr; 44(4):328-36. PubMed ID: 3566455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test and pituitary-adrenocortical function.
    Brown WA; Keitner G; Qualls CB; Haier R
    Arch Gen Psychiatry; 1985 Feb; 42(2):121-3. PubMed ID: 3977539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
    Guthrie SK; Vartanian L; Grunhaus L; Hariharan M; Pande A; Haskett RF
    Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF; Hunt G; Kerr K; Caterson I
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain sensitivity, evoked potentials, and the dexamethasone suppression test in depressed patients.
    Haier RJ
    Psychiatry Res; 1983 Nov; 10(3):201-6. PubMed ID: 6582527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
    Birmaher B; Dahl RE; Ryan ND; Rabinovich H; Ambrosini P; al-Shabbout M; Novacenko H; Nelson B; Puig-Antich J
    Am J Psychiatry; 1992 Aug; 149(8):1040-5. PubMed ID: 1636803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test with mildly to moderately depressed outpatients.
    Rabkin JG; Quitkin FM; Stewart JW; McGrath PJ; Puig-Antich J
    Am J Psychiatry; 1983 Jul; 140(7):926-7. PubMed ID: 6859319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.